Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis

Open access

Abstract

Objective: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences. Design: Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events. Results: The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival. Conclusion: In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2018-316801

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Protocol for scheduled endoscopic surveillance and therapy. Endoscopic surveillance was performed at yearly intervals. In case of detection of dominant stricture, repeated balloon dilatation was performed until sustained resolution of biliary obstruction was achieved. ERC, endoscopic retrograde cholangiography.
Figure 1 Protocol for scheduled endoscopic surveillance and therapy. Endoscopic surveillance was performed at yearly intervals. In case of detection of dominant stricture, repeated balloon dilatation was performed until sustained resolution of biliary obstruction was achieved. ERC, endoscopic retrograde cholangiography.CC BY-NC · PubMed Central
Figure 2 Endoscopic treatment until morphological resolution of dominant stricture. (A) White arrow indicates a dominant stricture of the common hepatic duct (left panel), repeated balloon dilation was performed (middle panel), until no more sign of previous stricture on cholangiography was detectable (right panel). (B) White arrow indicates a dominant stricture of the common bile duct with additional dilation of the upstream segment (left panel). Repeated balloon dilation was performed (middle panel) and finally only a slight narrowing of the bile duct as residuum of the previous stricture and regression of the upstream dilation was demonstrated (right panel).
Figure 2 Endoscopic treatment until morphological resolution of dominant stricture. (A) White arrow indicates a dominant stricture of the common hepatic duct (left panel), repeated balloon dilation was performed (middle panel), until no more sign of previous stricture on cholangiography was detectable (right panel). (B) White arrow indicates a dominant stricture of the common bile duct with additional dilation of the upstream segment (left panel). Repeated balloon dilation was performed (middle panel) and finally only a slight narrowing of the bile duct as residuum of the previous stricture and regression of the upstream dilation was demonstrated (right panel).CC BY-NC · PubMed Central
Figure 3 Flow chart. CCA, cholangiocarcinoma; DS, dominant stricture; OLT, orthotopic liver transplantation; PSC, primary sclerosing cholangitis.
Figure 3 Flow chart. CCA, cholangiocarcinoma; DS, dominant stricture; OLT, orthotopic liver transplantation; PSC, primary sclerosing cholangitis.CC BY-NC · PubMed Central
Figure 4 Kaplan-Meier analysis. Kaplan-Meier estimation confirmed the significant difference in transplantation-free survival between scheduled (red) and on-demand groups (blue) (17.9 vs 15.2 years; log-rank: p=0.008) (A). Further subgroup analysis revealed superior survival due to scheduled endoscopic intervention only in patients with the presence of DS (17.8 vs 11.1 years; log-rank: p<0.001) (B), whereas in patients without DS, transplantation-free survival was not affected by scheduled endoscopic surveillance (21.0 vs 18.7 years; log-rank: p=0.8) (C).
Figure 4 Kaplan-Meier analysis. Kaplan-Meier estimation confirmed the significant difference in transplantation-free survival between scheduled (red) and on-demand groups (blue) (17.9 vs 15.2 years; log-rank: p=0.008) (A). Further subgroup analysis revealed superior survival due to scheduled endoscopic intervention only in patients with the presence of DS (17.8 vs 11.1 years; log-rank: p<0.001) (B), whereas in patients without DS, transplantation-free survival was not affected by scheduled endoscopic surveillance (21.0 vs 18.7 years; log-rank: p=0.8) (C).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 73

Metadata

Authors
Rupp, C., Hippchen, T., Bruckner, T., Klöters-Plachky, P., Schaible, A., Koschny, R., Stiehl, A., Gotthardt, D. N., & Sauer, P.
Affiliations
  • University Hospital Heidelberg (DE)
  • Heidelberg University (DE)
Corresponding author
Rupp, Christian
Venue
Gut
Publisher
BMJ
Published
2019-03-25
Volume
68
Issue
12
Pages
2170-2178
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2924515033
Cited by
73
References
44
Citations by year
2026: 7 · 2025: 11 · 2024: 12 · 2023: 8 · 2022: 11 · 2021: 9 · 2020: 12 · 2019: 1
FWCI
5.26
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary sclerosing cholangitis, endoscopic retrograde cholangiopancreatography, transplant-free survival, endoscopic balloon dilation, bacterial cholangitis, hepatic decompensation, liver cirrhosis, inflammatory bowel disease, Mayo risk score
MeSH terms
Adult, Cholangiopancreatography, Endoscopic Retrograde, Constriction, Pathologic, Dilatation, Female, Follow-Up Studies, Hepatic Duct, Common, Humans, Male, Retrospective Studies, Cholangitis, Sclerosing, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1136/gutjnl-2018-316801
The paper
Rupp, C., Hippchen, T., Bruckner, T., Klöters-Plachky, P., Schaible, A., Koschny, R., Stiehl, A., Gotthardt, D. N., & Sauer, P. (2019). Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis. Gut. https://doi.org/10.1136/gutjnl-2018-316801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.